# Speaking the Language of the Business, with Jamey Lindholm

Page: https://stenobird.com/podcast/let-s-talk-quality-6567110/speaking-the-language-of-the-business-with-jamey-lindholm
Text version: https://stenobird.com/podcast/let-s-talk-quality-6567110/speaking-the-language-of-the-business-with-jamey-lindholm.md
Podcast: [Let's Talk Quality](https://stenobird.com/podcast/let-s-talk-quality-6567110)
Published: 2026-07-21T12:00:00+00:00
Episode link: https://rx-group.io/captivate-podcast/speaking-the-language-of-the-business-with-jamey-lindholm
Audio file: https://episodes.captivate.fm/episode/43c75b65-aa8a-47f2-875d-a2dde27cbd81.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/let-s-talk-quality-6567110/episodes/speaking-the-language-of-the-business-with-jamey-lindholm
Duration seconds: 2306

## Resource

Quality culture isn't built by SOPs. It's built in the small moments when a leader reinforces the right behaviour or lets the wrong one slide. Speaking the Language of the Business, with Jamey Lindholm. In today's episode I was joined by Jamey Lindholm, Vice President of Quality at R1 Therapeutics. I really wanted to speak to Jamey because she has led Quality through nearly every stage a career in this industry can throw at you: a first-in-class FDA approval at Seres Therapeutics, an acquisition by Merck KGaA at Springworks, and now building a Quality function completely from zero as R1's very first Quality hire. She has strong, hard-won views on how to get each of those right. Jamey's journey started almost by accident. She fell into a QC chemistry job at a small biotech straight out of university, got laid off a year later when the company ran out of funding, and then spent the next 20 years at Biogen, where she built the foundation of what she now calls "what good looks like" in Quality. From there she moved to Seres Therapeutics, where she led end to end Quality through the first FDA approval of a microbiome-derived oral therapy, then to Springworks through its acquisition by Merck KGaA, and now to R1 Therapeutics as its first Quality hire. What comes through across the whole conversation is a leader who has thought deeply about the difference between compliance and culture. Jamey is clear that Quality earns its seat at the leadership table not by enforcing SOPs, but by translating compliance into risk, into regulatory consequence, into business decisions that leadership teams actually understand. She is equally clear that the industry has a visibility problem. Almost nobody chooses Quality as a career at school, and she believes that is something the industry has…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/let-s-talk-quality-6567110/episodes/speaking-the-language-of-the-business-with-jamey-lindholm/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/let-s-talk-quality-6567110/speaking-the-language-of-the-business-with-jamey-lindholm.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.